» Articles » PMID: 12409674

New Insights into the Interactions Between T-cell Costimulatory Blockade and Conventional Immunosuppressive Drugs

Overview
Journal Ann Surg
Specialty General Surgery
Date 2002 Nov 1
PMID 12409674
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the precise in vivo interaction between T-cell costimulatory blockade and conventional immunosuppression in transplantation.

Summary Background Data: Blocking B7 or CD154 T-cell costimulatory activation pathways prevents allograft rejection in small and large animal transplant models and is considered a promising strategy for clinical organ transplantation.

Methods: A fully MHC-mismatched vascularized mouse cardiac allograft model was used to test the interactions between anti-CD154 or CTLA4Ig monotherapy and conventional immunosuppressive drugs in promoting long-term graft acceptance. The frequency of alloreactive T cell was measured by ELISPOT. Chronic rejection was examined by histology.

Results: Cyclosporine, tacrolimus, and anti-IL-2R monoclonal antibody therapy abrogated the effect of a single-dose protocol of anti-CD154 therapy. In contrast, rapamycin acted synergistically with anti-CD154 therapy in promoting long-term allograft survival. The addition of calcineurin inhibitors did not abolish this synergistic effect. Intense CD154-CD40 blockade by a multiple-dose schedule of anti-CD154 resulted in long-term graft survival and profound alloreactive T-cell unresponsiveness and overcame the opposite effects of calcineurin inhibitors. CTLA4Ig induced long-term graft survival, and the effect was not affected by the concomitant use of any immunosuppressive drugs.

Conclusions: The widespread view that calcineurin inhibitors abrogate the effects of T-cell costimulatory blockade should be revisited. Sufficient costimulatory blockade and synergy induced by CD154 blockade and rapamycin promote allograft tolerance and prevent chronic rejection.

Citing Articles

Immunomodulatory Strategies Targeting Dendritic Cells to Improve Corneal Graft Survival.

Schonberg A, Hamdorf M, Bock F J Clin Med. 2020; 9(5).

PMID: 32354200 PMC: 7287922. DOI: 10.3390/jcm9051280.


Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.

Zhao L, Fu Z J Immunol Res. 2018; 2018:5301548.

PMID: 29854842 PMC: 5964556. DOI: 10.1155/2018/5301548.


Nuclear calcium is required for human T cell activation.

Monaco S, Jahraus B, Samstag Y, Bading H J Cell Biol. 2016; 215(2):231-243.

PMID: 27810914 PMC: 5084645. DOI: 10.1083/jcb.201602001.


T Helper Cells Fate Mapping by Co-stimulatory Molecules and its Functions in Allograft Rejection and Tolerance.

Abdoli R, Najafian N Int J Organ Transplant Med. 2014; 5(3):97-110.

PMID: 25184030 PMC: 4149737.


The role of costimulatory molecules in directing the functional differentiation of alloreactive T helper cells.

Magee C, Boenisch O, Najafian N Am J Transplant. 2012; 12(10):2588-600.

PMID: 22759274 PMC: 3459149. DOI: 10.1111/j.1600-6143.2012.04180.x.


References
1.
Abraham R, Wiederrecht G . Immunopharmacology of rapamycin. Annu Rev Immunol. 1996; 14:483-510. DOI: 10.1146/annurev.immunol.14.1.483. View

2.
Kishimoto K, Dong V, Sayegh M . The role of costimulatory molecules as targets for new immunosuppressives in transplantation. Curr Opin Urol. 2000; 10(2):57-62. DOI: 10.1097/00042307-200003000-00002. View

3.
Vincenti F . The role of newer monoclonal antibodies in renal transplantation. Transplant Proc. 2001; 33(1-2):1000-1. DOI: 10.1016/s0041-1345(00)02303-4. View

4.
Smiley S, Csizmadia V, Gao W, Turka L, Hancock W . Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: implications for tolerance induction. Transplantation. 2000; 70(3):415-9. DOI: 10.1097/00007890-200008150-00005. View

5.
Hale D, Gottschalk R, Maki T, Monaco A . Use of CTLA4-Ig in combination with conventional immunosuppressive agents to prolong allograft survival. Transplantation. 1997; 64(6):897-900. DOI: 10.1097/00007890-199709270-00018. View